Long-term organ preservation possible even for rectal cancer
Top line: The latest data from the OPRA trial shows that nearly half of patients are stage II/III. rectal cancer Patients treated with complete neoadjuvant therapy had their rectum preserved for 5 years, but local tumor regrowth occurred primarily within the first 2 years. methodology: Many patients with locally advanced rectal cancer treated with fully […]